Synthetic DNA and mitochondrial donation: no need for donor eggs?

Area of Science:

• Biotechnology
• Genetics
• Bioethics

Background:

• Mitochondrial replacement therapy (MRT) aims to prevent mitochondrial disease transmission.
• Current MRT methods raise ethical concerns due to third-party DNA and donor risks.

Purpose of the Study:

• To explore synthetic DNA (synDNA) as an alternative to donor oocytes for creating mitochondria.
• To propose synthetic mitochondria as a more ethical option for preventing mitochondrial disease inheritance.

Main Methods:

• Conceptual exploration of synDNA technology for mitochondrial organelle construction.
• Ethical analysis comparing synDNA approach with existing MRT.

Main Results:

• SynDNA-based mitochondrial creation bypasses the need for donor oocytes and associated risks.
• The feasibility of synthetic mitochondria is suggested by advancements in synDNA technology.

Conclusions:

• Synthetic mitochondria present a potentially preferable ethical alternative to MRT.
• Further technical development is required to establish the viability of synthetic mitochondria.